Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1304-2025

BD Alaris Systems Manager , REF 9601 Infusion Safety Management Software Recall

BD Alaris Systems Manager , REF 9601 Infusion Safety Management Software

FDA recall Class I

Ongoing

FDA lists this Class I recall for BD Alaris Systems Manager , REF 9601 Infusion Safety Management Software. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1304-2025
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Feb 18, 2025
FDA report date
Mar 19, 2025
Quantity in commerce
Not reported
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

BD Alaris Systems Manager , REF 9601 Infusion Safety Management Software

Affected model & UDI checker

Search the exact identifiers published for Z-1304-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
9601BD Alaris Systems Manager , REF 9601 Infusion Safety Management SoftwareCheck source noticeNot specified
FDA code information

Software v12.5.1 or v12.5.2, and prior versions (4.33, 12.0.1, 12.0.2, 12.1, 12.1.2, 12.3) UDIs: 10885403960123 10885403519666 (10885403960116)

View the original FDA recall notice

Why was this product recalled?

Software issue that may result in outdated automated programming request(APR) being sent to the progressive care unit (PCU).

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did CareFusion 303, Inc. take?

On February 18, 2025, Becton, Dickinson issued a " Urgent Medical Device Product Correction" Notification. to affected consignees via Fed-Ex and E-Mail. 1. Users should review all infusion parameters pre-populated and confirm they are correct before pressing START as stated in the BD Alaris User Manual. 2. Disseminate this notice within your facility network to ensure that all concerned personnel are made aware of this issue. 3. BD Project Managers will engage with you to address any questions regarding this notice, and specific next steps for your facility. 4. Complete the attached Customer Response Form and return to the BD contact noted on the form, regardless of whether you have any of the impacted material. This will allow BD to confirm receipt of this notification. 5. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology